Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four segments: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company provides various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products and services. The company offers various products in the therapeutic areas including hypertension, cholesterol, diabetes, depression, anxiety, insomnia, psychosis, epilepsy, dementia, pain, headaches, inflammation, joint pain, gout, dipolar disorder, heartburn, acne, and bacterial and fungal infections. In addition, it provides medicines for cardiovascular health, metabolic syndrome; obsessive compulsive disorder; dry skin, eczema, psoriasis, rosacea, and skin infection; as well as women’s health including bacterial vaginosis, menopause, osteoporosis, and urinary. Adcock Ingram Holdings Limited was founded in 1891 and is headquartered in Midrand, South Africa. Adcock Ingram Holdings Limited is a subsidiary of The Bidvest Group Limited.